In the present study we describe three main findings; 1) tumor growth is significantly increased in HRG-deficient mice, 2) platelet activation is enhanced in mice lacking HRG and 3) the increased platelet activation mediates the accelerated angiogenic switch seen in HRG-deficient mice. The gene discussed is HRG; the disease is neoplasm.